COYA Fundamental Analysis - COYA THERAPEUTICS INC

Fundamental Rating

We assign a fundamental rating of 3 out of 10 to COYA. COYA was compared to 555 industry peers in the Biotechnology industry. No worries on liquidiy or solvency for COYA as it has an excellent financial health rating, but there are worries on the profitability. COYA does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year COYA has reported negative net income.

In the past year COYA has reported a negative cash flow from operations.

In the past 5 years COYA always reported negative net income.

COYA had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

The Return On Assets of COYA (-44.62%) is comparable to the rest of the industry.

Looking at the Return On Equity, with a value of -51.35%, COYA is in the better half of the industry, outperforming 64.87% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-44.62%
ROE	-51.35%
ROIC	N/A

ROA(3y)-66.21%

ROA(5y)-61.81%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for COYA so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

COYA does not have a ROIC to compare to the WACC, probably because it is not profitable.

Compared to 1 year ago, COYA has more shares outstanding

COYA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

COYA has an Altman-Z score of 9.39. This indicates that COYA is financially healthy and has little risk of bankruptcy at the moment.

The Altman-Z score of COYA (9.39) is better than 85.13% of its industry peers.

There is no outstanding debt for COYA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	9.39

ROIC/WACCN/A

WACC8.93%

2.3 Liquidity

A Current Ratio of 8.84 indicates that COYA has no problem at all paying its short term obligations.

The Current ratio of COYA (8.84) is better than 73.30% of its industry peers.

A Quick Ratio of 8.84 indicates that COYA has no problem at all paying its short term obligations.

Looking at the Quick ratio, with a value of 8.84, COYA is in the better half of the industry, outperforming 73.30% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	8.84
Quick Ratio	8.84

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

COYA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -23.26%.

COYA shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -39.87%.

EPS 1Y (TTM)-23.26%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-25.71%

Revenue 1Y (TTM)-39.87%

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%103.15%

3.2 Future

Based on estimates for the next years, COYA will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.51% on average per year.

Based on estimates for the next years, COYA will show a very strong growth in Revenue. The Revenue will grow by 53.49% on average per year.

EPS Next Y-25.98%

EPS Next 2Y-38.87%

EPS Next 3Y3.91%

EPS Next 5Y13.51%

Revenue Next Year100.27%

Revenue Next 2Y-62.74%

Revenue Next 3Y51.41%

Revenue Next 5Y53.49%

3.3 Evolution

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for COYA. In the last year negative earnings were reported.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for COYA. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y-38.87%

EPS Next 3Y3.91%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

COYA does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

COYA THERAPEUTICS INC

NASDAQ:COYA (6/27/2025, 8:00:00 PM)

After market: 6.14 +0.29 (+4.96%)

5.85

-0.05 (-0.85%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences

GICS IndustryBiotechnology

Earnings (Last)05-13 2025-05-13/bmo

Earnings (Next)N/A N/A

Inst Owners22.73%

Inst Owner Change4.94%

Ins Owners1.4%

Ins Owner Change0%

Market Cap97.81M

Analysts83.64

Price Target17.51 (199.32%)

Short Float %1.96%

Short Ratio4.82

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)1

Avg EPS beat(2)-42.05%

Min EPS beat(2)-121.22%

Max EPS beat(2)37.11%

EPS beat(4)2

Avg EPS beat(4)-19.65%

Min EPS beat(4)-121.22%

Max EPS beat(4)38.58%

EPS beat(8)4

Avg EPS beat(8)-13.69%

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)0

Avg Revenue beat(2)-93.76%

Min Revenue beat(2)-97.13%

Max Revenue beat(2)-90.39%

Revenue beat(4)0

Avg Revenue beat(4)-75.36%

Min Revenue beat(4)-100%

Max Revenue beat(4)-13.89%

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)6.63%

PT rev (3m)6.63%

EPS NQ rev (1m)-10.74%

EPS NQ rev (3m)-16.47%

EPS NY rev (1m)-18.61%

EPS NY rev (3m)8.02%

Revenue NQ rev (1m)2.17%

Revenue NQ rev (3m)-33.33%

Revenue NY rev (1m)6.44%

Revenue NY rev (3m)28.2%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	26.54
P/FCF	N/A
P/OCF	N/A
P/B	2.93
P/tB	2.93
EV/EBITDA	N/A

EPS(TTM)-1.06

EYN/A

EPS(NY)-1.87

Fwd EYN/A

FCF(TTM)-0.91

FCFYN/A

OCF(TTM)-0.91

OCFYN/A

SpS0.22

BVpS2

TBVpS2

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-44.62%
ROE	-51.35%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM	N/A

ROA(3y)-66.21%

ROA(5y)-61.81%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score3

Asset Turnover0.1

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	8.84
Quick Ratio	8.84
Altman-Z	9.39

F-Score3

WACC8.93%

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-23.26%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-25.71%

EPS Next Y-25.98%

EPS Next 2Y-38.87%

EPS Next 3Y3.91%

EPS Next 5Y13.51%

Revenue 1Y (TTM)-39.87%

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%103.15%

Revenue Next Year100.27%

Revenue Next 2Y-62.74%

Revenue Next 3Y51.41%

Revenue Next 5Y53.49%

EBIT growth 1Y-89.52%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-67.36%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-67.36%

OCF growth 3YN/A

OCF growth 5YN/A

COYA THERAPEUTICS INC (COYA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens